INTRODUCTION
, probable high-risk (PHR: 26, 53, 66) , and low-risk types (LR: 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81) . In particular, HPV 16 and 18 are considered to be the genotypes most strongly related to cervical cancer (9) .
Considering the close association between HPV and cervical cancer, the identification of HPV-infected women would enhance the quality of screening programs. In fact, epidemiological studies and follow-up analyses have shown that HPV infection precedes the spreading of cervical lesions (4) and that 15% of women with a negative Pap test but hosting high-risk HPV develop evident cytological lesions during the following 5 years (10) .
Several techniques are currently available to detect HPV in biological samples. In particular, the polymerase chain reaction (PCR) is considered to be adequate for clinical routine use because of its high sensitivity and suitability for analyzing a variety of biological specimens (fresh tissues, cytological smears, and formalin-fixed archival material) (11) .
The aim of the present study was to test PCR as a reliable tool to identify HPV in routine cytological smears, in order to supplement Pap testing in women with ambiguous Pap test results. Moreover, attention has been focused on the relationship between HPV types and early intraepithelial lesions.
MATERIALS AND METHODS

Clinical samples
A prospective study to test for the presence of HPV and to carry out its typing was performed from January 2000 through March 2003 in the Surgical, Molecular, and Ultrastructural Pathology Division at the University Hospital in Pisa, Italy. A total of 586 women were enrolled in this study on the basis of their clinical history of an abnormal Pap test result and/or colposcopy findings (including infections). The women, aged between 17 and 80 years (mean 36.6+9.9 years), had been referred to the Division of Gynecology and Obstetrics, Department of Procreative Medicine, University of Pisa and Pisa University Hospital. A conventional Pap test was performed at the same time of HPV analysis. Smears were read in a double-blind manner by two separate cytopathologists, with a senior cytopathologist reviewing all abnormal results.
DNA isolation
Cytological samples were collected by scraping the uterine cervix with an Ayre spatula, submerged upright into 70% sterile ethanol and sent to the laboratory.
Cervical cells were released from the spatula by stir-ring and the cell suspension was centrifuged at 2,000 x g for 5 minutes. A sample without scraped cells was used as negative control for each set of DNA extraction procedure. Pellets were washed in 1 mL of PBS buffer and centrifugation was repeated. Cells were resuspended in 600 µL of PBS buffer and total DNA was extracted using the QIAamp DNA Mini Kit (QIAGEN Valencia, Ca, USA) according to the manufacturer's instructions.
Amplification of HPV DNA by polymerase chain reaction
To test for DNA quality and for the presence of inhibitors, DNA aliquots (20 ng) were amplified, targeting a 220 bp fragment of the human β-actin gene. Primer sequences were 5'-TCA TCA CCA TTG GCA ATG AG-3' (forward) and 5'-CAC TGT GTT GGC GTA CAG GT -3' (reverse). Amplification conditions were 94°C for 5 minutes (1 cycle); 94°C for 30 seconds, 60°C for 45 seconds, 72°C for 30 seconds (35 cycles), and 72°C for 10 minutes (1 cycle).
HPV DNA from cervical cells was amplified using the degenerate consensus primers MY09 and MY11 (14) , designed in the L1 viral region in order to amplify a 450 bp fragment from 25 distinct genital HPV genotypes.
Aliquots of DNA (20 ng) were amplified in 20 µL of PCR reaction buffer containing MgCl 2 (1.5 mM), dNTPs (2.5 mM each), 10 pmol of oligonucleotide primers, 1 U AmpliTaq DNA Polymerase (AmpliTaq Gold, Applied Biosystems, Foster City, Ca, USA). A sample with only PCR mix was used as negative PCR control.
PCR was performed using a programmable Thermocycler (GeneAmp PCR System 9700, Applied Biosystems). Amplification conditions were 95°C for 10 minutes (1 cycle); 94°C for 30 seconds, 60°C for 30 seconds, 72°C for 45 seconds (10 cycles); 94°C for 30 seconds, 55°C for 30 seconds, 72 °C for 45 seconds (30 cycles); 72°C for 5 minutes (1 cycle); 80°C for 10 minutes (1 cycle). PCR products were analyzed by gel electrophoresis (3% agarose) followed by ethidium bromide staining. Samples were considered appropriate for diagnosis when the negative DNA and PCR controls were blank and β-actin was amplified. Samples negative for β-actin were excluded from the study. Samples positive for β-actin and negative for L1 were scored as negative.
Positive samples showing the 450 bp band corresponding to L1 were confirmed with another PCR reaction and scored as positive.
HPV genotyping by DNA hybridization
L1-amplified DNA fragments were employed for genotyping by hybridization with chemiluminescent labeled oligonucleotides for HPV 6, 11 (LR), 16, 18 and 33 (HR).
Heat-denatured amplification products (10 ng), including negative controls, positive controls and samples, were spotted onto nylon membrane (Biotrans Nylon Membranes, ICN, Irvine, Ca, USA), air-dried, and crosslinked under UV light. Replica membranes were prepared for each HPV probe. Oligonucleotide probes, selected within the L1 region (Tab. I), were labeled with the DIG oligonucleotide 3'-end labeling kit (Roche Molecular Biochemicals, Mannheim, Germany). Membranes were prehybridized in hybridization buffer (5xSSC; 1% blocking reagent; 0.1% Na-lauroylsarkosine; 0.02% SDS), and hybridized with digoxigenin-11-ddUTP (DIG-ddUTP) 3'end-labeled oligonucleotides for 6 hours at 38°C. Two high-stringency washes (0.1xSSC) were performed at 38°C, and hybridization signals were revealed by using the DIG Luminescent Detection Kit (Roche Molecular Biochemicals).
Statistical analysis
Statistical analysis was performed using GraphPad In-Stat version 3.00 (GraphPad Software, San Diego, Ca, USA). Differences between groups were tested by Fisher's test, chi-square test and chi-square for trend. In addition, we used the exact test of population differentiation, anal-ogous to Fisher's exact test, extended to R x K contingency tables (Harlequin software, Schneider).
RESULTS
Cytological diagnosis
Cytological evaluation of the 586 smears resulted in the following diagnoses according to the Bethesda 2001 classification (12, 13) : -177 (30.1%) "Negative for intraepithelial lesions or malignancy" (normal); -56 (9.6%) "Atypical Squamous Cells -Undeterminate
Significance" (ASC-US); -41 (7.0%) "Atypical Squamous Cells -cannot exclude HSIL" (ASC-H); -212 (36.2%) "Low-grade Squamous Intraepithelial Lesions" (LSIL); -100 (17.1%) "High-grade Squamous Intraepithelial Lesions" (HSIL). In 171 cases that had required histological examination, a biopsy was also available for the study.
HPV infection and cytological diagnosis
The prevalence of HPV infection was evaluated in all 586 women. HPV was found in 96 normal samples (54.3%), 36 ASC-US (64.3%), 164 LSIL (77.4%), 27 ASC-H (65.9%), and 90 HSIL (90%). A statistically significant correlation (p<0.0001, χ 2 test) emerged between the presence of the virus and abnormal cytological findings. Moreover, viral infection correlated significantly with the severity of the cytological diagnosis (p<0.0001, χ 2 test for trend) (Tab. II). Such correlation persisted (p<0.0001, χ 2 test) when LSIL and ASC-US were grouped as lowgrade lesions (LGL) and HSIL and ASC-H as high-grade lesions (HGL) (Tab. III), with the frequency of HPV infection increasing significantly according to lesion grade (p=0.01, χ 2 for trend). HPV genotype distribution was assessed with reference to the cytological diagnosis (Tab. II), and no statistically significant correlation was found, even when lesions were grouped into LGL and HGL (Tab. III). HR HPV types were found at a higher frequency (74.1% to 82.3%) throughout (Tab. II).
Correlation between HR HPV infection and age
The frequency of HR HPV was correlated with age (third, fourth, fifth decade, and over 50) and Pap test diagnosis (Tab. IV). The study was carried out in 325 HR HPV women, where the LSIL and ASC-US groups were classified as low-grade lesions and the HSIL and ASC-H groups as high-grade lesions. Among women infected with HR HPV, the severity of the cytological diagnosis increased significantly (p=0.003, χ 2 for trend) with age. Low-grade lesions peaked in the third decade, while high-grade lesions peaked in the fifth decade and over. The majority of women with normal Pap tests were in their fourth decade.
Cytological and histological diagnosis and HPV infection
Of the 586 women enrolled in the study, 171 (29.2%) underwent a biopsy. Comparative results from cytological and histological diagnoses are shown in Table  V . The correlation between cytological and histological diagnosis proved to be statistically significant (p<0.0001, exact test of population differentiation).
A correlation persisted (p<0.0023, exact test of population differentiation) when LSIL and ASC-US were grouped as low-grade lesions and HSIL and ASC-H as high-grade lesions. In particular, 11.1% of women with cytological low-grade lesions showed normal histology, 41.3% histological LSIL and 47.6% HSIL. Among women with cytological high-grade lesions, 12 
DISCUSSION
Cervical carcinoma represents the final event in the tumorigenic process originating with intraepithelial lesions, which are characterized by cytological and architectural abnormalities with diverse transformation potential. Accurate early diagnosis is crucial in the prevention of cervical cancer because, without treatment, a significant proportion of LSIL progresses to HSIL (15, 16) .
At present the Pap test has to be considered the best screening method and is most widely used for early diagnosis of cervical cancer. No other screening test for tumor prevention has been credited with reducing mortality to a similar extent (17) . The initial precipitous drop in the death rate after the introduction of the Pap test has slowed, however, and the mortality rate has remained virtually constant since the mid-eighties (18) . The technical procedure of the Pap smear has not undergone substantial modifications in the last 50 years. During this time some limitations have been highlighted, mainly related to the low sensitivity and specificity of the Pap test (3). The vast majority of false negative results are due to inaccuracies in sampling or slide preparation and interpretation, a problem sometimes caused by a heavy laboratory workload or lack of experience (19) . The issue has been exacerbated by the wide diffusion of the test accompanied by the proliferation of laboratories with limited expertise, thus leading to an increase in false negative results and interlaboratory variability (21) . Screening programs that involve novel detection techniques beside traditional cytology would therefore represent a useful complement.
Cervical carcinoma was the first human solid tumor identified as being of viral origin (20) . HPV has been found in virtually all cervical tumors and has been shown to represent a major risk factor in the genesis of this cancer (21) . Viral genotypes 16 and 18 are mainly associated with HSIL (9) . HPV infection precedes the occurrence of most intraepithelial lesions and the identification of the viral genotype within lesions appears to have diagnostic predictive value (21) .
HPV infection is a common event (22) whose frequency varies according to the population examined and the method of analysis. In our study more than 54% of the 177 women with normal Pap smears were carrying an infection (Tab. II). This percentage was higher than those reported in the literature (15-30%), as revealed by PCR analysis (23) . Such discrepancy can be explained if we consider the peculiar nature of the group under study, which was mainly composed of women who had been referred to a gynecologist, and was therefore not representative of the general population taking part in Pap testbased screening programs. Our data are a further confirmation of the low sensitivity of the Pap test in revealing HPV infection.
Also, in agreement with a number of studies (21, 24) , we found a significant correlation (p<0.0001, χ 2 test for trend) between the incidence of HPV infection and the severity of the cytological diagnosis, with 90% HPV-positive HSIL versus 77.4% HPV-positive LSIL (Tab. II).
The most recent revision of the Bethesda classification system recommends for Pap smears originally classified as ASCUS to be subdivided in ASC-US and ASC-H according to their cytological abnormalities (25) . We found the incidence of HPV infection to be comparable in the two new subclasses, with 64.3% HPV-positive ASC-US versus 65.9% HPV-positive ASC-H. Our data, although limited to a restricted set of patients, point to the need of additional research to verify the applicability of the Bethesda classification system in its revised version.
Interestingly, when HSILs were grouped with ASC-H and LSILs with ASC-US, the HPV frequencies significantly (p<0.0001) decreased (83.0% and 74.7%, respectively), possibly because ASC includes benign cytological alterations undistinguishable from real atypia.
When HPV genotypes and cytological diagnosis were compared, a strong prevalence of HR HPV was found in all categories: normal (82%), LGL (76%), and HGL (80%). The pattern remained unaltered by subdividing LGL and HGL into ASC-US/LSIL and ASC-H/HSIL, respectively. Such discrepancy from the population data could be explained by our patients having been somehow preselected for the study or by hypothesizing a prevalence of HR HPV within the local population.
Many women happen to be affected by transient HPV infections, generally asymptomatic and of little clinical consequence, rarely progressing to high-grade lesions (26) . The persistence of viral DNA is essential to the development and even more to the maintenance and progression of intraepithelial cervical neoplasia (27) . Women with chronic HPV infection are considered at true high risk for HSIL (21) . When the presence of HR HPV, cytological diagnosis, and age were considered together, we found 3 different patterns for infected women with no cytological abnormality, those hosting an LGL or a HGL. In particular: a) the percentage of women with an HR viral genotype showing absence of cytopathological features remained constant in the different age groups; b) the frequency of women hosting an LGL significantly decreased with age, from the third to the sixth decade; c) the frequency of women with an HGL showed an opposite trend, increasing with age. Our data support the hypothesis that HPV requires cofactors to induce cancer initiation and progression (28) . The age-related HGL increase could be associated with genetic changes occurring as a consequence of aging, while HPV on its own would mainly act in the fertile period. The presence of a large number of HGLs in women under 30 years supports the usefulness of extending the HPV test to an early age, even in the absence of cytological abnormalities (29, 30) .
In the group of 171 women for whom biopsy material was available we compared the Pap test results with the histological diagnosis. Of the 34 women with a normal Pap test, 24 (70.6%) were diagnosed as having intraepithelial lesions, including 6 (17.7%) HSIL. Of the 137 women with a positive Pap result, 16 (11.7%) showed no lesions, 49 (35.8%) were diagnosed with LSIL, and 72 (52.6%) were diagnosed with HSIL (Tab. V and VI). This high sensitivity of the Pap test (83.4%) can be explained by the peculiar nature of the group under study, which was made up of women referred to a gynecologist. The frequency of viral infection, which was higher in women with HSIL (90%, in accordance with the literature) than in women with LSIL (64%), suggests that at least a proportion of LSIL does not progress to HSIL (31) . It emerges that surgical treatment (loop electrosurgical excision procedure) in the presence of LSIL could be limited to patients with HPV infection, while HPV-negative women would be eligible for follow-up with only Pap test.
In our hands, contrary to most reports (32) , the Pap test appears to have a slightly higher sensitivity than the PCR HPV test in identifying both HSIL (92% and 90%, respectively) and LSIL (73% and 64%, respectively). Again, this may be attributable to the selected population, together with the high standards adopted in sampling and smear preparation by a gynecologist, and the involvement of highly experienced cytopathologists.
The present paper supports the importance of complementing the Pap test with the PCR HPV test to improve the diagnostic rate of histologically diagnosed HSIL, thus raising the reliability to 99% of histological HSIL. Nevertheless, it must be taken into account that the introduction of HPV molecular testing would contribute to increasing the anxiety of women who are positive to the test, an issue that should be tackled by providing comprehensive and accurate information. Indeed, for women with normal Pap tests who are positive for HPV more frequent and accurate follow-up visits should be suggested, while HPV negativity would be highly reassuring.
Based on our results, HPV testing should be performed at well-defined age ranges, twice within the screening programs (30 and 50 years of age). Cost-effectiveness has to be taken into account, although the additional costs could be balanced by extending the interval between Pap smears from 3 to 5 years in HPV-negative women.
HPV detection currently represents a valuable marker to allow early diagnosis of high-grade cervical lesions. It also constitutes the first step in the search for novel molecular markers to be utilized in cervical cancer screening programs.
